Blood Eosinophil and Risk of Exacerbation in Chronic Obstructive Pulmonary Disease Patients: A Retrospective Cohort Analysis

References

• SahaS, BrightlingCE. Eosinophilic airway inflammation in COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(1):39–47. doi:10.2147/copd.2006.1.1.3918046901
   PubMedGoogle Scholar
• BafadhelM, McKennaS, TerryS, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662–671. doi:10.1164/rccm.201104-0597OC21680942
   PubMed Web of Science ®Google Scholar
• SinghD, AgustiA, AnzuetoA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-201930846476
   PubMed Web of Science ®Google Scholar
• WedzichaJA, SeemungalTAR. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. doi:10.1016/S0140-6736(07)61382-817765528
   PubMed Web of Science ®Google Scholar
• SchleichF, CorhayJ, LouisR. Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD. Eur Respir J. 2016;47(5):1562–1564. doi:10.1183/13993003.01659-201526846827
   PubMed Web of Science ®Google Scholar
• WagenerAH, de NijsSB, LutterR, et al. External validation of blood eosinophils, FE NO and serum periostin as surrogates for sputum eosinophils in asthma. Thorax. 2015;70(2):115–120. doi:10.1136/thoraxjnl-2014-20563425422384
   PubMed Web of Science ®Google Scholar
• SiddiquiSH, GuasconiA, VestboJ, et al. Blood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(4):523–525. doi:10.1164/rccm.201502-0235LE26051430
   PubMed Web of Science ®Google Scholar
• PascoeS, LocantoreN, DransfieldMT, BarnesNC, PavordID. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015;3(6):435–442. doi:10.1016/s2213-2600(15)00106-x25878028
   PubMed Web of Science ®Google Scholar
• PavordID, LettisS, LocantoreN, et al. Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD. Thorax. 2016;71(2):118–125. doi:10.1136/thoraxjnl-2015-20702126585525
   PubMed Web of Science ®Google Scholar
• BarnesNC, SharmaR, LettisS, CalverleyPMA. Blood eosinophils as a marker of response to inhaled corticosteroids in COPD. Eur Respir J. 2016;47(5):1374–1382. doi:10.1183/13993003.01370-201526917606
   PubMed Web of Science ®Google Scholar
• Vedel-KroghS, NielsenSF, LangeP, VestboJ, NordestgaardBG. Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen general population study. Am J Respir Crit Care Med. 2016;193(9):965–974. doi:10.1164/rccm.201509-1869OC26641631
   PubMed Web of Science ®Google Scholar
• ZeigerRS, TranTN, ButlerRK, et al. Relationship of blood eosinophil count to exacerbations in chronic obstructive pulmonary disease. J Allergy Clin Immunol Pract. 2018;6(3):944–954. doi:10.1016/j.jaip.2017.10.00429153881
   PubMed Web of Science ®Google Scholar
• CouillardS, LarivéeP, CourteauJ, VanasseA. Eosinophils in COPD exacerbations are associated with increased readmissions. Chest. 2017;151(2):366–373. doi:10.1016/j.chest.2016.10.00327746201
   PubMed Web of Science ®Google Scholar
• BafadhelM, GreeningNJ, Harvey-DunstanTC, et al. Blood eosinophils and outcomes in severe hospitalized exacerbations of COPD. Chest. 2016;150(2):320–328. doi:10.1016/j.chest.2016.01.02626851799
   PubMed Web of Science ®Google Scholar
• ZysmanM, DesleeG, CaillaudD, et al. Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:1819–1824. doi:10.2147/COPD.S12978728694695
   PubMed Web of Science ®Google Scholar
• SongJH, LeeC, KimJW, et al. Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:2455–2464. doi:10.2147/COPD.S12932128860740
   PubMed Web of Science ®Google Scholar
• HoJ, HeW, ChanMTV, et al. Eosinophilia and clinical outcome of chronic obstructive pulmonary disease: a meta-analysis. Sci Rep. 2017;7(1):13451. doi:10.1038/s41598-017-13745-x29044160
   PubMed Web of Science ®Google Scholar
• BafadhelM, PavordID, RussellREK. Eosinophils in COPD: just another biomarker? Lancet Respir Med. 2017;5(9):747–759. doi:10.1016/S2213-2600(17)30217-528601554
   PubMed Web of Science ®Google Scholar
• YoudenWJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32–35. doi:10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.CO;2-315405679
   PubMed Web of Science ®Google Scholar
• ErdalM, JohannessenA, EaganTM, BakkeP, GulsvikA, GrønsethR. Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients. Int J Chron Obstruct Pulmon Dis. 2016;11:2099–2108. doi:10.2147/COPD.S10872027621614
   PubMed Web of Science ®Google Scholar
• KreindlerJL, WatkinsML, LettisS, Tal-SingerR, LocantoreN. Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD. BMJ Open Respir Res. 2016;3(1):e000151. doi:10.1136/bmjresp-2016-000151
   PubMed Web of Science ®Google Scholar
• YunJH, LambA, ChaseR, et al. Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2018;141(6):2037–2047. doi:10.1016/j.jaci.2018.04.01029709670
   PubMed Web of Science ®Google Scholar
• HastieAT, MartinezFJ, CurtisJL, et al. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017;5(12):956–967. doi:10.1016/S2213-2600(17)30432-029146301
   PubMed Web of Science ®Google Scholar
• BafadhelM. Eosinophils in COPD: are we nearly there yet? Lancet Respir Med. 2017;5(12):913–914. doi:10.1016/S2213-2600(17)30445-929146300
   PubMed Web of Science ®Google Scholar
• LandisS, SurukiR, MaskellJ, BonarK, HiltonE, ComptonC. Demographic and clinical characteristics of COPD patients at different blood eosinophil levels in the UK clinical practice research datalink. COPD. 2018;15(2):177–184. doi:10.1080/15412555.2018.144127529558236
   PubMedGoogle Scholar
• MiravitllesM, MonteagudoM, SolntsevaI, AlcazarB. Blood eosinophil counts and their variability and risk of exacerbations in COPD: A population-based study. Arch Bronconeumol. 2020;S0300-2896(19):30623–30624. doi:10.1016/j.arbres.2019.12.015
   Web of Science ®Google Scholar
• TuratoG, SemenzatU, BazzanE, et al. Blood eosinophilia neither reflects tissue eosinophils nor worsens clinical outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;197(9):1216–1219. doi:10.1164/rccm.201708-1684LE29035097
   PubMed Web of Science ®Google Scholar
• BrusselleG, PavordID, LandisS, et al. Blood eosinophil levels as a biomarker in COPD. Respir Med. 2018;138:21–31. doi:10.1016/j.rmed.2018.03.01629724389
   PubMed Web of Science ®Google Scholar
• YuWC, TaiEL, FuSN, et al. Treatment of patients with chronic obstructive pulmonary disease as practised in a defined hong kong community: a cross-sectional pilot survey. Hong Kong Med J. 2011;17(4):306–314.21813900
   PubMedGoogle Scholar
• OshagbemiOA, BurdenAM, BraekenDCW, et al. Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts. Am J Respir Crit Care Med. 2017;195(10):1402–1404. doi:10.1164/rccm.201701-0009LE28165763
   PubMed Web of Science ®Google Scholar